Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dermo-epidermal regeneration refers to the integrated process by which both the **dermis (the deeper connective tissue layer)** and the **epidermis (the outermost cell layer)** of the skin repair themselves after injury. This process is driven by numerous cell types, primarily **epidermal stem cells** and **dermal fibroblasts**. **Regeneration** involves re-epithelialization, collagen deposition, and restoration of skin appendages like hair follicles. The process is orchestrated by **cytokines, growth factors, signaling pathways (notably Wnt/β-catenin)**, and the interplay between resident stem cells, immune cells, and extracellular matrix components[1][3][7]. "Dermo-epidermal regeneration" describes a physiological response or outcome, not a specific molecular entity amenable to targeted drug binding or inhibition. No canonical molecule, abbreviation, or single therapeutic target exists for “dermo-epidermal regeneration”; it is a biological process, and use of this as a drug target identifier is incorrect[1][3][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dermo-epidermal regeneration.